These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 37565061)

  • 21. Exploring the molecular targets of dietary flavonoid fisetin in cancer.
    Syed DN; Adhami VM; Khan N; Khan MI; Mukhtar H
    Semin Cancer Biol; 2016 Oct; 40-41():130-140. PubMed ID: 27163728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concurrent regulation of the transcription factors Nrf2 and ATF4 mediates the enhancement of glutathione levels by the flavonoid fisetin.
    Ehren JL; Maher P
    Biochem Pharmacol; 2013 Jun; 85(12):1816-26. PubMed ID: 23618921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fisetin: A bioactive phytochemical with potential for cancer prevention and pharmacotherapy.
    Kashyap D; Sharma A; Sak K; Tuli HS; Buttar HS; Bishayee A
    Life Sci; 2018 Feb; 194():75-87. PubMed ID: 29225112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fisetin Alleviates Atrial Inflammation, Remodeling, and Vulnerability to Atrial Fibrillation after Myocardial Infarction.
    Liu L; Gan S; Li B; Ge X; Yu H; Zhou H
    Int Heart J; 2019 Nov; 60(6):1398-1406. PubMed ID: 31666455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carnosic acid and fisetin combination therapy enhances inhibition of lung cancer through apoptosis induction.
    Shi B; Wang LF; Meng WS; Chen L; Meng ZL
    Int J Oncol; 2017 Jun; 50(6):2123-2135. PubMed ID: 28440400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic Potential and Molecular Mechanisms of the Multitargeted Flavonoid Fisetin.
    Rauf A; Abu-Izneid T; Imran M; Hemeg HA; Bashir K; Aljohani ASM; Aljohani MSM; Alhumaydhi FA; Khan IN; Bin Emran T; Gondal TA; Nath N; Ahmad I; Thiruvengadam M
    Curr Top Med Chem; 2023; 23(21):2075-2096. PubMed ID: 37431899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fisetin inhibits laryngeal carcinoma through regulation of AKT/NF-κB/mTOR and ERK1/2 signaling pathways.
    Zhang XJ; Jia SS
    Biomed Pharmacother; 2016 Oct; 83():1164-1174. PubMed ID: 27551764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Fisetin in Selected Malignant Neoplasms in Women.
    Markowska A; Antoszczak M; Kacprzak K; Markowska J; Huczyński A
    Nutrients; 2023 Nov; 15(21):. PubMed ID: 37960338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fisetin Alleviates Neointimal Hyperplasia via PPAR
    Pei F; Pei H; Su C; Du L; Wang J; Xie F; Yin Q; Gao Z
    Oxid Med Cell Longev; 2021; 2021():6625517. PubMed ID: 33968295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fisetin inhibits growth, induces G₂ /M arrest and apoptosis of human epidermoid carcinoma A431 cells: role of mitochondrial membrane potential disruption and consequent caspases activation.
    Pal HC; Sharma S; Elmets CA; Athar M; Afaq F
    Exp Dermatol; 2013 Jul; 22(7):470-5. PubMed ID: 23800058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticancer activity of Fisetin against the human osteosarcoma cell lines involves G2/M cell cycle arrest, mitochondrial apoptosis and inhibition of cell migration and invasion.
    Xing C; Zhang Y; Su R; Wu R
    J BUON; 2020; 25(2):1022-1027. PubMed ID: 32521901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fisetin from Dietary Supplement to a Drug Candidate: An Assessment of Potential.
    Mirza MA; Padhi S; Mohapatra S; Mahmood S; Iqbal Z
    Curr Pharm Biotechnol; 2024 Apr; ():. PubMed ID: 38716552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fisetin inhibits pristine-induced systemic lupus erythematosus in a murine model through CXCLs regulation.
    Xu SP; Li YS
    Int J Mol Med; 2018 Dec; 42(6):3220-3230. PubMed ID: 30272314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paclitaxel and the dietary flavonoid fisetin: a synergistic combination that induces mitotic catastrophe and autophagic cell death in A549 non-small cell lung cancer cells.
    Klimaszewska-Wisniewska A; Halas-Wisniewska M; Tadrowski T; Gagat M; Grzanka D; Grzanka A
    Cancer Cell Int; 2016; 16():10. PubMed ID: 26884726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crosstalk between Fisetin-induced Apoptosis and Autophagy in Human Oral Squamous Cell Carcinoma.
    Park BS; Choi NE; Lee JH; Kang HM; Yu SB; Kim HJ; Kang HK; Kim IR
    J Cancer; 2019; 10(1):138-146. PubMed ID: 30662534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances in potential of Fisetin in the management of myocardial ischemia-reperfusion injury-A systematic review.
    Prem PN; Sivakumar B; Boovarahan SR; Kurian GA
    Phytomedicine; 2022 Jul; 101():154123. PubMed ID: 35533608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Dietary Flavonoid Fisetin Causes Cell Cycle Arrest, Caspase-Dependent Apoptosis, and Enhanced Cytotoxicity of Chemotherapeutic Drugs in Triple-Negative Breast Cancer Cells.
    Smith ML; Murphy K; Doucette CD; Greenshields AL; Hoskin DW
    J Cell Biochem; 2016 Aug; 117(8):1913-25. PubMed ID: 26755433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fisetin inhibits liver cancer growth in a mouse model: Relation to dopamine receptor.
    Liu XF; Long HJ; Miao XY; Liu GL; Yao HL
    Oncol Rep; 2017 Jul; 38(1):53-62. PubMed ID: 28560391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fisetin Reduces Cell Viability Through Up-Regulation of Phosphorylation of ERK1/2 in Cholangiocarcinoma Cells.
    Kim N; Lee SH; Son JH; Lee JM; Kang MJ; Kim BH; Lee JS; Ryu JK; Kim YT
    Anticancer Res; 2016 Nov; 36(11):6109-6116. PubMed ID: 27793939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fisetin, a phytopolyphenol, targets apoptotic and necroptotic cell death in HepG2 cells.
    Sundarraj K; Raghunath A; Panneerselvam L; Perumal E
    Biofactors; 2020 Jan; 46(1):118-135. PubMed ID: 31634424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.